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ABSTRACT 
 Despite improved life expectancy compared to medical management alone, 
Ventricular Assist Device (VAD) recipients show survival rates of 80% at 12 months and 
70% at 24 months. A large portion of VAD-associated mortality results from increased 
risk of stroke with an event frequency reported between 14-47%. Recent concerns have 
been raised about unprecedented increases of thrombus formation in VAD recipients 
with subsequent reports pointing towards implantation techniques as a critical 
contributor to these events. Thus, the overall prognosis with mechanical support can 
improve by advancing the surgeon’s approach to VAD implantation. Previous studies 
using Computational Fluid Dynamics (CFD) were aimed at reducing stroke rates by 
tailoring the VAD outflow graft (VAD-OG) angle to direct any circulating emboli away 
from the cerebral vessels. In-vitro, or benchtop, models are often developed as 
computational counterparts. In order to accurately model the hemodynamics in the 
cardiovascular system, pulsatile flow must be mimicked. This is achieved in the 
computational domain by what is called a Windkessel model. This project seeks to 
develop a physical analogy to the Windkessel model for use in the benchtop experiments. 
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CHAPTER ONE: INTRODUCTION 
 
Background 
Heart failure is a major first-world epidemic currently affecting over five million 
people in the United States with an anticipated increase of 46% by 2030 and an annual 
economic impact of over thirty billion dollars [1,2] . Ventricular assist devices (VADs) are 
now the mainstay for patients with end-stage heart failure refractory to pharmacotherapy 
while awaiting heart transplantation. However, the increasing gap between transplant 
donors and recipients has led to an increase in long-term use of VADs as a destination 
therapy and will continue to expand with an expected two-fold increase of heart failure 
patients over the next thirty years [3-6]. 
The two main types of VADs used within the last decade include pulsatile and 
continuous-flow pump systems where the pulsatile design mimics native cyclic perfusion 
of the circulatory system [7]. Even though continuous-flow VADs are known to reduce 
hemodynamic pulsatility they have shown improved device durability and clinical 
outcomes, emerging as the new standard for mechanical support [8-11]. Despite 
improved survival compared to medical management alone, VAD recipients show 
survival rates of 80% at 12 months and 70% at 24 months for the continuous-flow systems 
[12]. A large portion of VAD-associated mortality results from increased risk of stroke 
with an event frequency reported between 14-47% [12-14]. Thrombus can enter the VAD 
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from the heart or may develop in-situ [15, 16]. The in-situ formation of thrombi in VADs 
is caused by various mechanisms including platelet activation associated with non-
physiological flow patterns such as stagnation, recirculation and high shear stresses [17-
19]. These thrombi eventually dislocate into the circulation as thromboemboli until they 
reach a destination vessel. Cerebral thrombo-embolization has been reported to occur 
considerably more often than non-cerebral [20]. The thromboembolic risks introduced by 
VADs have been addressed by improving device design and optimizing anticoagulation 
therapy. Although adequate anticoagulation is essential, the optimal prophylactic 
regiment during VAD support has not yet been determined [21-23]. Additionally, recent 
concerns have been raised about unprecedented increases of thrombus formation in VAD 
recipients reported in two large studies from The New England Journal of Medicine and The 
Journal of Heart and Lung Transplantation [24, 25]. More recent reports point to 
implantation techniques as a critical contributor to these thromboembolic events with the 
continuous-flow VAD design [26, 27].  Thus, the overall prognosis with mechanical 
support must improve by advancing VAD designs as well as the surgeon’s approach to 
VAD implantation.  
Previous studies using Computational Fluid Dynamics (CFD) were aimed at 
reducing stroke rates by tailoring the VAD outflow graft location and angle to direct any 
circulating emboli away from the cerebral vessels. Rather than focusing on anti-
thrombotic properties, these studies compared flow characteristics of select VAD outflow 
graft (VAD-OG) configurations to identify an overall optimal angle of anastomosis. 
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Recent studies suggest that sub-optimal VAD-OG configurations serve as an 
independent risk factor for stroke in both a generic synthetic vascular anatomy and 
patient-specific vascular anatomy [31, 32, 34, and 35]. Moreover, an in-vitro benchtop 
study has been previously conducted to validate steady flow computational models [33]. 
They conclude that tailoring the VAD-OG anastomosis during surgery may reduce the 
risk for stroke by as much as 50%. 
It has been hypothesized that non-steady or pulsatile models are essential for 
capturing the phenomena of thrombogenesis and embolization, particularly in reference 
to VAD applications as explored above. Introducing pulsatility in the in-vitro model 
significantly increases the complexity of the problem and must be tackled before setting 
out to construct a full analogous in-vitro model to the computational counterpart. The 
key to modeling pulsatile blood flow is matching the physiological impediment to flow: 
vascular input impedance. 
 
Vascular Impedance 
Any pulsatile hemodynamic model representing the human cardiovascular 
system must faithfully recreate vascular impedance, otherwise known as the impediment 
to cyclic flow. All oscillatory systems depart from the hydraulic analogy of Ohm’s law 
for electrical theory – the relationship between pressure, flow and resistance: ∆P = Q*R 
where ∆P is the pressure difference (analogous to the voltage difference), Q is volumetric 
flow rate (analogous to current) and R is resistance (analogous to drag) of the system. In 
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pulsatile systems, where Ohm’s resistance, R, is rendered insufficient, impedance is the 
solitary physical principle that fully describes the resistance to dynamic flow. Since our 
system is pulsatile, we must aim to recreate the input impedance (Z), defined as the 
collective ratio of pressure and flow across a spectrum of frequencies at a single point. 
The input impedance represents the impediment to flow for oscillatory, or pulsatile, 
systems beyond a specific point until the oscillations are damped out (the venous bed in 
our case of the cardiovascular system). We are able to use the principle of impedance to 
approximate vessel mechanics for any vessel with corresponding flow and pressure 
Figure 1: Modulus and phase curves 
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waveforms. Simultaneous pressure and flow waves can yield an abundance of 
hemodynamic information and for our purposes, provides us with the ability to derive 
two properties essential for input impedance: modulus and phase (Figure 1, adapted 
from Westerhof, et al). Modulus and phase yields information essential to recreate the 
relationship between pressure and flow and are the very parameters needed to replicate 
the vascular mechanics specified in our counterpart CFD study. This is accomplished by 
translating representative electrical impedance circuits coupled to each branch vessel 
used in our CFD model (Figure 2) into a physical in-vitro construct. Each “compartment” 
contains a representative vascular electrical model. 
Figure 2 - Computational multi-scale model 
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The Windkessel 
The computational model uses 3-D CFD to evaluate the probabilities of thrombo-
embolization of the major branch vessels of the aorta. However, the CFD needs specified 
boundary conditions in order to solve the governing equations of the fluid in the 3-D 
domain. In order to derive the boundary conditions, our group makes use of an 
impedance circuit that represent the mechanics of the rest of the vascular system beyond 
the specific geometry of interest – the input impedance (Figure 2). This circuit is a 
combination of electrical elements including a resistor, capacitor, and inductor. Each of 
these elements numerically correspond to hydraulic equivalents being fluid resistance, 
vessel compliance, and blood inertia respectively (Figure 3). Using electrical theory, we 
can predict the pressure and flow waveforms in a vessel if values for each element are 
Figure 3 - Electrical-hydraulic analogy 
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known. This analogous electrical circuit representative of vascular input impedance is 
widely known as the Windkessel circuit. 
 
Objectives 
The goal of this project is to develop a physical windkessel circuit - analogous to 
the computational windkessel circuit. The aim is to accurately re-create the vascular input 
impedance, which in turn will mimic the pressure and flow waveforms produced by the 
computational counterpart. With this new ability to model pulsatile flow in the 
cardiovascular system, a huge array of doors open in regards to in-vitro benchtop 
modeling, such as validating an ongoing pulsatile CFD study currently underway at our 
institution. After design and manufacturing of the physical windkessel elements, an 
arbitrary branch vessel of the aorta will be used as the test mule for proof of concept of 
the physical windkessel. 
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CHAPTER TWO: METHODS 
 
Determining Windkessel Component Values 
 The multi-scale model used at our institution includes a variation of the 2-element 
Windkessel lumped-parameter model (LPM), or circuit; containing a single inductor, 
capacitor, and resistor (Figure 4). We choose to simplify our model by omitting the 
inductance, as it is often approximately 2 orders of magnitude less than the other 
parameters, rendering its contribution to the input impedance insignificant. In order to 
construct physical windkessel elements corresponding to the electrical elements, we must 
have the values for each element when we are only given pressure and flow waveforms 
to depart from. A number of numerical techniques will be employed to yield the correct 
values for each windkessel element. For the physical Windkessel, vascular compliance 
will be modeled using compliance air chambers containing a measured water column 
under pressurized air. Resistance will be modeled using Poiseuille’s law for parallel tubes 
and developing a flow-independent resistor with laminar flow conditions. The details of 
our current Windkessel design are detailed as follows: 
Figure 4 - 2-element Windkessel Circuit 
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Starting with only the pressure and flow waveforms, we must solve the inverse problem 
– that is find the parameters of the governing equation for the circuit of interest that most 
closely match the pressure and flow waveforms that are given. For systems in steady-
state the total impedance is simply the peripheral resistance (RP), and Ohm’s law applies. 
The steady-state value for each waveform is simply the time average over one cycle. 
𝑅𝑃 =
1
𝑛
∑ 𝑃𝑖
𝑛
𝑖=1
1
𝑛
∑ 𝑄𝑖
𝑛
𝑖=1
          (1) 
Using these concepts, RP can be calculated directly using equation 1 using pressure (P), 
volume flow rate (Q), and the total number of data points (n) all in one cycle leaving only 
the compliance (C) to be derived. The compliance is not so easily calculated however; 
several methods have been reported in literature for estimating it using a variety of 
different inputs. These include the time decay method [28], area method [29], and pulse 
pressure method [30]. These methods have not proven to be robust, so a least-squares 
approach minimization scheme has been developed to find the compliance value that 
yields the best fit to the given pressure data. Since all of the compliance estimation 
methods produce better or worse results in comparison to each other for different target 
waveforms and are all easily employed, each method described above is utilized and the 
best fit is used as an initial guess in the minimization numerical technique to reduce 
computational time. Once the initial guess has been found, it is implemented into the 2-
element Windkessel governing equation: 
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𝑑𝑃(𝑡)
𝑑𝑡
=
𝑄(𝑡)
𝐶
−
𝑃
𝐶∗𝑅𝑃
                                                      (2) 
Where it is solved numerically using the 4th order Runge-Kutta method. The Sum of the 
Square of the Error (SSE) to the original pressure waveform is then evaluated using 
equation (3) and the guess for compliance is updated. This process is iterated until the 
value for the SSE falls within a certain tolerance.                  
𝑆𝑆𝐸 = ∑(𝑃𝑖 − 𝑃𝑜𝑟𝑖𝑔𝑖𝑛𝑎𝑙𝑖)
2
𝑛
𝑖=1
                                                       (3) 
 Once the solution is converged, the coefficient of determination (R2) is calculated to 
ensure the solution is acceptable. Now that we have found the values for each element, 
the physical components can be designed and constructed. 
 
Windkessel Design Calculations 
Peripheral Resistance Modules 
Previous studies demonstrated that resistor modules for benchtop applications 
can maintain constant resistance independent of flow using a packed honeycomb tube 
design. This design includes multiple glass capillary tubes with sub-millimeter lumen 
diameters packed together within a single PVC conduit. Resistance (R) can be calculated 
using Poiseuille’s law – the hydraulic equivalent of Ohm’s law, in which:  
 𝑅 =
Δ𝑃
𝑄
=
8𝜇𝑙
𝜋𝑁𝑟4
                                                                (4) 
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where ΔP is the pressure drop across the resistor, Q is the volume flow rate, N is the 
number of capillary tubes, r is the capillary tube inner radius, l is the capillary tube length, 
and µ is the dynamic fluid viscosity. Because we only have control over the capillary tube 
radius and the quantity of them (the length is generally the same for all radii), resistance 
contour lines are generated by varying these parameters, enabling us to easily pick from 
an array of combinations keeping our approach modular. From equation 3, the Reynold’s 
number is calculated from equation 5 for each combination to ensure laminar flow and 
any combination that transitions into turbulent flow is thrown out due to the restriction 
of equation 4 requiring laminar flow to hold true. 
𝑅𝑒 =  
2∗𝑄𝑚𝑎𝑥
𝜋𝑁𝑟𝜐
                                      (5) 
Re is the Reynold’s number for each capillary tube, Qmax is peak systolic flow through the 
entire vessel, r is inner radius of each parallel pipe, N is number of parallel pipes and ν is 
the kinematic fluid viscosity. Once laminar flow is verified, construction may proceed. 
Compliance Chambers 
Equation 6 is used to calculate the compliance (C), which is a function of the 
chamber geometry and fluid levels: 
                                          𝐶 =
Δ𝑉𝑎𝑖𝑟
Δ𝑃𝑎𝑖𝑟
=
𝑉𝑎𝑖𝑟−𝐴𝑡𝑎𝑛𝑘ℎ𝑓𝑙𝑢𝑖𝑑
𝑃𝑓𝑙𝑢𝑖𝑑 − 𝜌𝑔ℎ𝑓𝑙𝑢𝑖𝑑
                                                  (6)                                          
where Vair is volume of air in the tank, Pair is the air pressure of the tank, Atank is the 
transverse cross sectional area of the chamber, hfluid is the fluid height within the chamber, 
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Pfluid is the average fluid pressure over the cardiac cycle, ρ is the fluid density, and g is 
the gravitational constant. Rearranging, we then solve for fluid height: 
ℎ𝑓𝑙𝑢𝑖𝑑 =
𝐶𝑃𝑓𝑙𝑢𝑖𝑑 −𝐴𝑡𝑎𝑛𝑘ℎ𝑡𝑜𝑡𝑎𝑙
𝜌𝑔𝐶− 𝐴𝑡𝑎𝑛𝑘
                                                   (7) 
With fluid height, we can then subtract column hydrostatic pressure to yield air tank 
pressure using Equation 8: 
𝑃𝑎𝑖𝑟 = 𝑃𝑓𝑙𝑢𝑖𝑑 − 𝜌𝑔ℎ𝑓𝑙𝑢𝑖𝑑                                                    (8) 
With known fluid column height, chamber height, and chamber diameter, we can then 
proceed with tank construction. Clear PVC with standard pipe fittings will be sized to 
specification and assembled into a preliminary compliance chamber. 
 
Equipment 
Our input flow will be generated using a computer-programmable research pump 
system capable of driving up to 6 L/min of fluid (Physiopulse 100 Flow System, Shelly 
Medical Imaging Technologies, Ontario, Canada) using a CPU-controlled servo motor 
(Figure 5). This system is able to generate any user-defined arbitrary waveform. This 
arbitrary function generator will be used to replicate the cardiac input flow waves 
specifically generated by our computational model by uploading the digital file into the 
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onboard CPU. Pressure and flow data acquisition will be achieved using pre-calibrated 
Omegadyne® PX-309-015 pressure transducers (Omegadyne Inc., Sunbury, OH), a Millar 
Mikro-Tip® catheter pressure transducer (Millar, Inc., Houston, TX), and TurboFlow® 
FT-210 flow rate sensors (Gems Sensors & Controls, Plainville, CT) coupled to a 
PowerLabs data acquisition system (ADInstruments Inc., Colorado Springs, CO) and 
LabChart data management software (ADInstruments Inc., Colorado Springs, CO). 
 
Performance Evaluation 
 For this proof of concept, all calculations and testing will use water as the fluid 
instead of a water-glycerin mixture which would mimic the properties of blood. This will 
have no effect on the results. Each element will be individually tested first, then brought 
together to form the Windkessel circuit and tested as a whole. The resistor will be 
individually tested by running different volume flow rates and obtaining the pressure 
Figure 5 - Computer-programmable cardiac pump 
14 
 
drop, then using equation 5 to calculate the measured resistances which will also validate 
the flow-independent design. The characteristic mechanical effect on flow generated by 
compliance as seen in figure 1 is a delayed relationship between pressure and flow, 
represented by a phase-shift (φshift) and evaluated theoretically using equation 9. Because 
resistance does not contribute to the phase angle, chamber compliance is the only variable 
and thus can be validated individually by comparing ϕshift between measured and 
theoretical at any given frequency. 
𝜙𝑠ℎ𝑖𝑓𝑡 = 𝑡𝑎𝑛
−1(−𝜔𝐶𝑅)                                                         (9) 
To validate the system as a whole, Fourier analysis is performed on the pressure 
and flow waveforms for both measured and theoretical results from which the modulus 
(M) and phase-angle (φangle) for each harmonic can be extracted using equations 10 and 
11, respectively. The input impedance modulus (Z) is then calculated from equation 12. 
φangle is measured from 0° and not to be confused with ϕshift which is the difference of 
φangle for pressure and flow, as described by equation 13. 
𝑀𝑛 = √𝐴𝑛 + 𝐵𝑛                                                           (10) 
  𝜙𝑎𝑛𝑔𝑙𝑒𝑛 = 𝑡𝑎𝑛
−1 (
𝐵𝑛
𝐴𝑛
)                                                            (11) 
𝑍𝑛 =
|𝑀𝑃𝑛|
|𝑀𝑄𝑛|
                                                                        (12) 
𝜙𝑠ℎ𝑖𝑓𝑡𝑛 = 𝜙𝑃𝑛 − 𝜙𝑄𝑛                                                             (13) 
Here, n denotes the Fourier harmonic, A and B are the Fourier coefficients, MPn and MQn 
are the moduli of pressure and flow, respectively, and φP and φQ are the phase angles of 
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pressure and flow, respectively. The input impedance modulus and phase shift 
completely describe the system and therefore can be used to comprehensively compare 
theoretical and measured waveforms which will validate the design of the physical 
Windkessel model.  
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CHAPTER THREE: RESULTS 
 
Windkessel Component Construction  
This project is focused on the development of a model, therefore arbitrary values 
are to be used to verify the Windkessel components. Pressure and flow waveforms from 
a subclavian artery were used in the back calculation of Windkessel parameters using the 
scheme previously described. Target Windkessel values were calculated to be: 1.53 
mmHg*s/mL and 0.376 mL/mmHg for the resistance and compliance, respectively. 
Resistor 
 Starting with capillary tubes that are 10 cm long and 0.75mm inner diameter, these 
parameters were inserted into equation 4 and the resistor was calculated to have 60 
capillary tubes within the duct as seen in figure 6a. The resistor module, pictured in figure 
6b, was constructed with a quick-disconnect attachment (the white part to the right) to 
aid in cleaning. Since the capillary tubes are so small, flow is obstructed when debris gets 
caught in the resistor, thus changing the resistance value. This must be avoided at all 
Figure 6 – Physical resistor 
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costs, since the pressure waveform output by the Windkessel model is highly dependent 
on the resistance value.  
Compliance Chamber 
The compliance chamber was built purely from PVC tubing, using a cylinder that 
is 16 inches tall and 2 inches in diameter. This geometry yielded a necessary fluid height 
Figure 7 – Physical Windkessel Model 
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of 12 inches to achieve our target compliance value of 0.376 mL/mmHg. The compliance 
chamber was constructed so fluid would flow straight through it as pictured in figure 7.  
 
Benchmarking the Physical Windkessel 
The test sections were emptied into a tank at the same height to erase any 
contributions to the pressure due to the weight of the fluid as seen in figure 8. After 
Figure 8 – Reservoir tank 
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construction of the resistance module, it was tested individually first by hooking it up to 
a simple flow loop with pressure transducers before and after the resistor as shown in 
figure 9. The Omegadyne pressure transducer (area A) was placed downstream, and a 
pressure catheter was placed upstream so that the port (area C) could be placed far 
enough away from the resistor (area B) to avoid the tripping of turbulence due to the 
Figure 9 – Resistor test flow loop 
Figure 10 – Resistor performance curve 
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irregular geometry, yet still be able to place the catheter’s point of measurement close to 
the start of the resistor (tip of arrow). The pressure drop across the resistor was measured 
at various flow rates throughout the range that is physiologically possible to prove our 
resistor was in fact a flow-independent design. The measured resistance was 1.506 ± 0.107 
mmHg*s/mL from 0.0-1.0 L/min flow rates and increasing to 2 mmHg*s/mL up to 2.0 
L/min as seen in figure 10. This verifies the resistor design since the flow range that stays 
Figure 11 – Windkessel test setup 
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fully flow-independent also lies in the majority of the heart cycle. The physical 
Windkessel as a whole was tested next by introducing the compliance chamber into the 
flow loop (figure 11) and placing both a flow meter (circled in red) and pressure 
transducer (circled in green) before the Windkessel module. The input flow waveform 
was then used to solve equation 2 using a 4th order Runge-Kutta numerical technique 
yielding a pressure waveform that is shown in figure 12 as the blue line. That same input 
flow waveform (green line) was programmed into the Shelley Medical pump and ran 
through the test section. The result is plotted as the red line. After both the experimental 
Figure 12 – Pressure waveforms 
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and theoretical pressure waveforms were obtained, Fourier analysis was performed 
using equations 10-13 like previously described. The results are shown in figure 13 below. 
Figure 13 – Impedance modulus and phase curves 
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Discussion 
The results show that the impedance modulus agrees extremely well between 
theoretical and experimental data as expected. The phase shift shows good agreement for 
the first and second harmonic as it tends to the negative phase shift range as expected 
from figure 1 but starts to diverge quickly after that. There are a number of reasons for 
this – the phase shift has been shown to be extremely sensitive to measurements where a 
small error magnifies quickly when calculating the phase. Some of this error has been 
revealed to be due to wave reflections within the fluid. As you can see in figures 7 and 
11, the fluid is pumped using ½ inch diameter rigid tubing and into the 3 inch diameter 
compliance chamber with that cross-sectional area change being a sharp step. Whenever 
there are sudden large cross-sectional area changes, pressure wave reflections occur and 
this in effect alters what the correct pressure waveform being measured should look like 
thus giving way to the error in phase shift calculations. The reflections can be seen in 
figure 12 circled in black. Another reason there is seemingly large error in the higher 
harmonics is because the input flow waveform is a simple sine wave, therefore the 
amplitudes of the waves at higher harmonics are very small and sensitive to differences 
in phase angle. 
The resistance can be verified by looking at the impedance modulus at the 0th 
harmonic, which was measured to be 2.329 mmHg*s/mL. This is higher due to again, the 
cross-sectional area step change of the compliance chamber, creating a large recirculation 
zone which is widely known to cause a pressure drop – thus adding to the resistance.  
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CHAPTER FOUR: CONCLUSION AND FUTURE WORK 
 The performance of the physical Windkessel model has shown to be fairly accurate 
in consideration of the electrical Windkessel model that was prescribed. The resistor 
design proved to be extremely accurate and robust, achieving every objective. The 
compliance chamber design made it easy to operate and adjust the fluid height for minor 
tuning of the model. The impedance modulus and phase, the metrics that fully 
characterize the system, both showed good agreement in the first few harmonics which 
are vastly more important than the rest in cardiovascular models. 
Changes are to be made to the compliance chamber to capture another degree of 
accuracy by avoiding the sudden step change. This physical Windkessel Model will be 
constructed for all of the necessary branch vessels and employed in a full-scale benchtop 
model of the LVAD circulatory problem. The results from this investigation will prove to 
be extremely important for establishing modeling techniques for cardiovascular studies. 
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